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Negative results are an important building block in the development of scientific thought, primarily because most
likely the vast majority of data is negative, i.e., there is not a favorable outcome. Only very limited data is positive,
and that is what tends to get published, albeit alongside a sub-set of negative results to emphasize the positive
nature of the positive results. Yet, not all negative results get published. Part of the problem lies with a traditional
mind-set and rigid publishing frame-work that tends to view negative results in a negative light, or that only tends
to reward scientists primarily for presenting positive findings. This opinion piece indicates that in addition to a
deficient mind-set, there are also severe limitations in the availability of publishing channels where negative results
could get published.
Keywords: COPE, Editorial bias, Negative results, STM publishers, Traditional peer reviewThere are, as I see it, two crises in science. The first re-
lates to trust, in part, due to weaknesses and failures of
the traditional peer review system [1]. The second, a cri-
sis in reproducibility [2], is a knock-on effect of the first,
partly because of lack of a widespread culture and ac-
ceptance of the need and importance of negative results.
Negative results are extremely important in science
because they indicate what doesn’t work. Such valuable
clues thus form the basis of new hypothesis testing and
new experiments that could then allow a focus on a nar-
rower set of variables, or options. The existence of nega-
tive results is an essential building block for science. Dr.
Haiko Sprott defines a negative result as “a scientist is
not able to show … a positive effect of the experiment”.
[3]. Sandercock [4] provides a three-prong definition for
negative results, including a third more somber, but
valid, ethical perspective, within the context of studies
involving human and animal subjects. These may be
summarized as: 1) “truly inconclusive with ‘no evidence
of effect’” (also referred to as neutral or uninformative
results); 2) a study in which “any effect is too small to be
worthwhile pursuing”; 3) “clear evidence of harm when
benefit had been expected”.
Many, if not most, studies that show a set of data tend
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sults, either to show that the results are themselves posi-
tive, or to indicate that the negative ones were not
successful. Thus, the intrinsic nature of many scientific
papers already incorporates negative (or not so positive)
results into its framework. Consequently, there are few
outlets to publish purely negative results (Table 1) sim-
ply because: a) the majority of papers already cover a
solid – but limited – selection of negative results, as ex-
plained above; b) mainstream science, technology and
medicine (STM) publishers prefer to see a focus on the
“positive” and not on the negative; c) scientists who
would like to present only negative results might fear
the equally negative perception by peers should they
present only negative results. Related to c), the publica-
tion pressures that scientists face, and limits on time,
cause them to set aside negative results in favor of posi-
tive ones in order to maximize their output, thus in-
creasing scientific bias [5], and skepticism. This bias may
lead science and scientists to know “more and more
about less and less” [6]. Finally, excessive emphasis on
the P value [7] inhibits authors from submitting results
that are not significantly different while editors are
skeptical about accepting results that either do not in-
clude statistical analyses, or that do not report signifi-
cant differences. Adding to this complex background,
McCormick [8] correctly points out one more limitationss article distributed under the terms of the Creative Commons Attribution
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Table 1 Journals that focus exclusively on negative results (listed alphabetically)
Journal name Publisher URL (start datea)
All Results Journals (Chem, Nano,
Biol, Phys)*
SACSIS http://arjournals.com/ (2010)
Journal of Articles in Support of the
Null Hypothesis*
Reysen Group http://www.jasnh.com/ (2002)
Journal of Errology Unknown http://www.bioflukes.com/ (unknown; discontinued; site down)
Journal of Interesting Negative
Results
Unknown http://jinr.site.uottawa.ca/ (2008; discontinued)
Journal of Negative Observations in
Genetic Oncology
Unknown http://www.path.jhu.edu/NOGO (1997; discontinued; site down)
Journal of Negative Results in
BioMedicine*
BioMed Central (Springer
Science + Business Medium)a
http://www.jnrbm.com/ (2002)
Journal of Negative Results –
Ecology and Evolutionary Biology
JNR-EEB.org http://jnr-eeb.org/index.php/jnr (2002; discontinued)
Journal of Pharmaceutical Negative
Results*
Wolters Kluwer http://www.pnrjournal.com/ (2010)
Nature Negative Results section* Nature Publishing Group http://www.nature.com/jcbfm/journal/v30/n7/full/jcbfm201051a.html (2010)b
The Journal of Spurious Correlations International Sociology
Association
http://www.jspurc.org/intro2.htm (2005; discontinued)
The International Journal of




negative-null-results.html (unknown; discontinued; site down)
The Null Journal Unknown http://null-journal.com/about.html (2009; discontinued)
University of Colorado Database of
Negative Results
University of Colorado https://sites.google.com/site/cujonr/ (2011; discontinued)
*Only these journals are still actively publishing (true up until June 29, 2015)
aIn several cases, if the URL link is not working, or if details about the publisher or the archives could be found, or if no volumes had been published in at least
one year, these journals were classified as “discontinued”.
bA special section of Journal of Cerebral Blood Flow & Metabolism, dedicated to negative results, was started in 2010. It is unclear if this section applies to other
NPG journals.
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ing reviewers canny enough to separate the null-result
wheat from the ill-executed chaff”. Consequently, there
might be a wealth of negative results with very positive
messages and learning experiences that ought to be pub-
lished to exploit novel avenues for new hypothesis testing.
So why then, apart from the negative psychological
perception of negative results, are more negative results
not published? There may also be two additional under-
lying factors, but ultimately these might be reflecting the
negative aspects of positive psychology [9], which in
terms of negative results in science, and their perception,
are negatively viewed. As alluded to above, the first per-
tains to the limited selection of outlets (i.e., journals) in
which such results could be published (Table 1). Even
so, out of 13 journals that were initiated, only five re-
main active. Most mainstream STM publishers would
most likely turn away a set of negative data results. This
may also be associated with pride, as many/most STM
journals wish only to showcase “the best” data sets, and,
perhaps subconsciously, be actively downgrading the im-
portance of negative data by not showcasing it. Other
journals, especially those that continue to use a trad-
itional print format, will prefer to accept positive resultsover negative results, i.e., an in-built editorial bias, asso-
ciated with the psychology of the negative.
Consequently, the number of journals that can be found
that deal exclusively with negative results is extremely lim-
ited (Table 1), most of which have been discontinued, and
none of which carries an impact factor (IF). Unfortunately,
the IF continues to serve – incorrectly – as a measure of
quality [10], and many countries adopt a compensation-for-
IF policy for their scientists, in which the latter are
rewarded, sometimes monetarily, by publishing in IF jour-
nals. So, this vicious cycle of biased selection of IF journals,
by scientists and their research institutes, automatically
then tends to exclude the negative results. When there is
no incentive by the “system” to embrace negative results,
then these are also underplayed – if not totally ignored –
by scientists themselves. The reality on the ground, i.e., the
number of viable outlets for the publication of negative
results (Table 1), is counter to the ethical basis that Sander-
cock [4] alludes to, namely that the results of human trials
should be made publicly available, especially the negative
results. His argument is that before any research project
proposal is approved, it should reflect the entirety of the
literature’s findings. Thus, if the scientific community
has willfully ignored negative results, then not only does
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valuable waste of resources (time, human effort, money,
etc.) to discover what has already been discovered, but
simply not reported, because there were insufficient, or
inadequate, channels to demonstrate such negative data.
Focusing on positive results by eliminating negative or
unsuccessful options has particular relevance in R&D in
the pharmaceutical industry, to reduce the waste of
funds and to optimize resources [11]. Most likely as a
result of these negative associations of not reporting
negative results, reporting negative findings is now a re-
quirement of the Consolidated Standards of Reporting
Trials (CONSORT), specifically for clinical trials [12].
Curiously, the Committee on Publication Ethics (COPE)
has one mandatory clause in its code of conduct for COPE
member journal editors related to negative results that
states: “14.3. Studies reporting negative results should not
be excluded”. Thus, the importance of negative results is
recognized, but they are simply not woven into the publish-
ing psyche of scientists and editors or into the publishing
fabric of most STM publishers. Thus, the mind set of edi-
tors, and their receptiveness towards negative results, needs
an overhaul [13].
Most likely such a mental frame-work underlying the
selection against negative in favor of positive ones will
not only require a structural change, but also a mental
or psychological one, including better training of editors
to recognize the importance of negative results, and to
distinguish negative results from bad science. Scientists
also need to be taught to better appreciate the import-
ance of their negative results, although this appreciation
can only evolve when there are suitable and sufficient
channels for them to express/publish their negative re-
sults. Providing additional and expansive ideas, through
the public presentation of negative results, also aids in
expanding the discussion, provides new vistas and per-
spectives, and assists those who wish to conduct similar
experiments, with valuable experimental signs of what
not to do, aptly summarized by Pfeffer and Olsen [14]:
“it only takes one counter observation to falsify it”.
That said, the reader is duly warned that negative re-
sults should not be equated with bad science, lack of sci-
entific rigor, or with poor experimental design. Negative
results focus exclusively on those results that did not
support a hypothesis, or prove a desired “positive” out-
come, and should never be equated with, senso lato, bad
science. The inflation of positive results, simply because
there is a lack of negative ones, which have not been
duly reported, may inflate the “positive” nature of some
studies, and in some cases, these may turn out to be
unreproducible. This was demonstrated in the Bayer
HealthCare and Amgen cases, the latter not being able
to replicate as much as 89 % of its published findings
in prominent cancer journals, leading the NationalInstitutes of Health (NIH) to contemplate the imple-
mentation of rules to validate positive results, and to
counter the lack of incentives to publish negative results
[15]. Thus, reporting negative results is one practical
way to increase reproducibility. Journals that are luke-
warm to the presentation of negative results could
present a simple solution: the inclusion of a supplemen-
tary online file that summarizes the negative results. In
fact, such a policy could or should be a standard prac-
tice. Such a solution would resolve the “gap” pointed out
in a comment, made in [8], by Prof. Scott E. Kern, a
Johns Hopkins pathologist: “If you sequence 13,000
genes, and only about 1,300 of them show mutations,
then the other 11,700 sequences deposited are essentially
null results”.
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